NewcelX Ltd
NCEL
4 hedge funds and large institutions have $467K invested in NewcelX Ltd in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
79% more capital invested
Capital invested by funds: $261K → $467K (+$207K)
0.24% less ownership
Funds ownership: 0.69% → 0.45% (-0.24%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4.68K |
| 2 |
CA
CoreCap Advisors
Southfield,
Michigan
|
+$75 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.1K |
NCEL Hedge Fund Activity: Q2 2025 in Review
4 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in NewcelX Ltd (NCEL) for Q2 2025, worth a combined $467K — up 79% from $261K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NCEL positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $4.68K. The largest seller was UBS Group, cutting an estimated $20.1K.
- 4 institutional investors held NewcelX Ltd (NCEL) as of Q2 2025, up from 2 in Q1 2025.
- Funds reported $467K of NewcelX Ltd stock for Q2 2025, up 79% quarter-over-quarter.
- 2 funds opened new NewcelX Ltd positions in Q2 2025 and 0 closed out, a net change of +2 holders.
- The largest NewcelX Ltd buyer in Q2 2025 was Morgan Stanley, an estimated $4.68K added.
- The largest NewcelX Ltd seller in Q2 2025 was UBS Group, an estimated $20.1K sold.
Based on aggregated 13F filings for Q2 2025.